Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of LY3154885 in Healthy Participants

The main purpose of this study is to learn more about the safety and side effects of LY3154885 when given by mouth to healthy participants. The study will have up to four parts. Each participant will enroll in only one part. The study will last up to 70 days for each participant, including screening and follow-up.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY3154885 - Capsule

Administered orally.

Drug - Placebo - Capsule

Administered orally.

Drug - Itraconazole

Administered orally.

Drug - LY3154885 - Tablet

Administered orally.

Additional Information

Official Study Title

Single- and Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3154885 in Healthy Subjects

Clinical Trial ID

NCT04014361

ParticipAid ID

bkRx6a